Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Disease sites
  • Breast
  • Capture of stage

Capture of stage

  • Charts and Tables

    Charts and Tables

    Figure 3.4

    Percentage of incident cases for which stage data were available in provincial registries, by province, top 4 cancers and all cancers — 2012 and 2013 diagnosis years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “—” Data not available.

    SK: “All cancers” does not include non-melanoma skin cancers diagnosed in SK. Denominator includes incident cases for which stage is recorded as “Not Applicable” since SK does not differentiate between “Not Applicable” and “Not Available” categories.

    ON: Stage 0 excluded.

    NB: From 2008 onward, only the 4 most common cancers (breast, colorectal, lung and prostate) are staged.

    NL: Staging not complete for 2014 so it is not possible to report on “All cancers (2013).”

    Data source: Provincial cancer agencies and programs.

    Data Table

    JurisdictionCancer CategoryNumber of casesPercent (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BCFour most common cancers (2012)13,349100.0100.0100.0
    BCFour most common cancers (2013)13,050100.0100.0100.0
    BCAll cancers (2012)––––
    BCAll cancers (2013)––––
    ABFour most common cancers (2012)9,089100.0100.0100.0
    ABFour most common cancers (2013)8,82899.999.9100.0
    ABAll cancers (2012)18,78699.999.9100.0
    ABAll cancers (2013)18,62599.999.999.9
    SKFour most common cancers (2012)3,22199.999.8100.0
    SKFour most common cancers (2013)3,25499.999.8100.0
    SKAll cancers (2012)5,27591.490.792.1
    SKAll cancers (2013)5,34891.390.692.0
    MBFour most common cancers (2012)3,771100.0100.0100.0
    MBFour most common cancers (2013)3,750100.0100.0100.0
    MBAll cancers (2012)6,906100.0100.0100.0
    MBAll cancers (2013)6,988100.0100.0100.0
    ONFour most common cancers (2012)32,04784.584.184.8
    ONFour most common cancers (2013)32,24492.091.792.3
    ONAll cancers (2012)47,39968.468.068.7
    ONAll cancers (2013)47,77573.272.973.5
    QCFour most common cancers (2012)––––
    QCFour most common cancers (2013)––––
    QCAll cancers (2012)––––
    QCAll cancers (2013)––––
    NBFour most common cancers (2012)2,57098.798.399.1
    NBFour most common cancers (2013)2,60499.999.8100.0
    NBAll cancers (2012)––––
    NBAll cancers (2013)––––
    NSFour most common cancers (2012)3,242100.0100.0100.0
    NSFour most common cancers (2013)3,109100.0100.0100.0
    NSAll cancers (2012)5,725100.0100.0100.0
    NSAll cancers (2013)5,695100.0100.0100.0
    PEFour most common cancers (2012)556100.0100.0100.0
    PEFour most common cancers (2013)512100.0100.0100.0
    PEAll cancers (2012)915100.0100.0100.0
    PEAll cancers (2013)869100.0100.0100.0
    NLFour most common cancers (2012)1,87799.999.7100.0
    NLFour most common cancers (2013)1,958100.0100.0100.0
    NLAll cancers (2012)3,10299.899.7100.0
    NLAll cancers (2013)––––

    + Expand Table

    “—” Data not available.

    SK: “All cancers” does not include non-melanoma skin cancers diagnosed in SK. Denominator includes incident cases for which stage is recorded as “Not Applicable” since SK does not differentiate between “Not Applicable” and “Not Available” categories.

    ON: Stage 0 excluded.

    NB: From 2008 onward, only the 4 most common cancers (breast, colorectal, lung and prostate) are staged.

    NL: Staging not complete for 2014 so it is not possible to report on “All cancers (2013).”

    Data source: Provincial cancer agencies and programs.

  • Data specifications

    Data specifications

    Definition: The percentage of cancer incident cases for which valid data on stage at diagnosis are available and collected by the provincial cancer agencies

    Numerator: Number of stageable* incident cases in the provincial cancer registry (stage 0 – IV including occult and “Unknown”)

    Denominator: Total number of stageable incident cases (stage 0 through to “Not Available”)

    Exclusions:

    • Age (at diagnosis) 0 – 17
    • Non-melanoma skin cancer (M8050-8110 with site code C44.0 to C44.9)
    • Colorectal reporting for appendix C18.1
    • Lymphoma codes M-95 to M-98, all sarcoma codes

    Data source: Provincial cancer agencies

    Measurement timeframe: 2012 and 2013 diagnosis years

    Stratification variable: Province, disease site (1. All cancers; 2. Four most common cancers – breast, prostate, colorectal, and lung (NSCLC, SCLC))

    Provinces submitting data: BC, AB, SK, MB, ON, NB, NS, PE, NL

    Province-specific notes:

    • AB: Hematology, sarcoma and melanoma morphologies were removed from the site-specific cancers. All 2012-2013 invasive primaries are collaboratively staged and once coded there should be no cases with missing/not available stage values. Currently “Not Available” indicates the number of cases that have a missing stage at the time of data pull as the registry status was not complete and staging information is still to come. Certain skin cancers (C44 codes) with morphologies other than basal-squamous are not staged according to Alberta Cancer Registry (ACR) rules. For this indicator, codes 8002, 8073 and 8803 are included as NSCLC.
    • SK: “All cancers” do not include non-melanoma skin cancers diagnosed in the province (topography codes C44.0 to C44.9 and histology codes not in 8720-8790). The denominator includes incident cases for which stage is recorded as “Not Applicable” since SK does not differentiate between “Not Applicable” and “Not Available” categories.
    • ON: Data submitted exclude stage 0 cases.
    • NB: From 2008 onwards, only the four most common cancers (breast, colorectal, lung and prostate cancers) are staged.
    • NL: Staging is not complete for 2014 so it is not possible to report on all cancers (2013).

    Notes:

    1. The group stages for cancer incident cases were classified by AJCC Cancer Staging 7th edition.
    2. By AJCC, cancer incident cases are categorized in terms of stage as:
      1. Stageable: including stage 0, stage I through stage IV, stage unknown
      2. Not Applicable: Not stageable through AJCC
      3. Not Available: Cases for which stage data is not available or invalid
      4. Unknown: Cases for which there is insufficient information to ascertain a definitive stage
    3. Stage 0 includes in-situ and invasive cancer cases. Stage occult for lung cancer cases are included as well.
    4. Breast cancer cases only include females.
  • Related indicators

    Related Indicators

    Stage distribution

    Distribution of cases by stage at diagnosis for prostate cancer – 2013 diagnosis year
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation